They showed, indeed, that the increase in proteasomal degradation was the molecular mechanism of the reduction of DVL3 induced by AMPK activators, such as metformin, evidencing the importance of DVL3 in the oncogenesis of cervical cancer and highlighting the importance of targeting DVL3 in cervical cancer via AMPK activators. This evidence concerns the gene DVL3 and cervical carcinoma.